Advertisement
UK markets open in 2 hours 8 minutes

  • NIKKEI 225

    38,242.05
    -32.00 (-0.08%)
     

  • HANG SENG

    18,155.28
    +392.25 (+2.21%)
     

  • CRUDE OIL

    79.59
    +0.59 (+0.75%)
     

  • GOLD FUTURES

    2,328.40
    +17.40 (+0.75%)
     

  • DOW

    37,903.29
    +87.37 (+0.23%)
     

  • Bitcoin GBP

    45,763.94
    -2,234.23 (-4.65%)
     

  • CMC Crypto 200

    1,262.94
    -76.13 (-5.69%)
     

  • NASDAQ Composite

    15,605.48
    -52.34 (-0.33%)
     

  • UK FTSE All Share

    4,418.60
    -11.65 (-0.26%)
     
Money:

Family finances

Who is the breadwinner in your family and does it matter?

Ionis to present at upcoming investor conferences

PR Newswire
·1-min read

CARLSBAD, Calif., April 1, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences:

Ionis logo (PRNewsfoto/Ionis Pharmaceuticals, Inc.)
Ionis logo (PRNewsfoto/Ionis Pharmaceuticals, Inc.)

  • 23rd Annual Needham Virtual Healthcare Conference on Monday, April 8, 2024

  • 2024 RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024

  • BofA Securities Health Care Conference 2024 on Tuesday, May 14, 2024

  • 45th Annual Goldman Sachs Global Healthcare Conference on Wednesday, June 12, 2024

A live webcast of these presentations can be accessed on the Investors & Media section of the Ionis website at https://ir.ionispharma.com/events-and-presentations/upcoming-events. Replays will be available on the Ionis website within 48 hours and will be archived for a limited time.

ADVERTISEMENT

About Ionis Pharmaceuticals
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visit Ionispharma.com and follow us on X (Twitter) and LinkedIn.

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-302102970.html

SOURCE Ionis Pharmaceuticals, Inc.